Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, July 29, 2014
Technology Networks
 
Register | Sign in
Home Page>Latest Webcasts

  Webcasts

Scientific News
UK Government Must Do More to Reduce Risk of vCJD Infection
Report recommends that UK Government commission a full assessment of the risks currently faced by the UK blood supply.
NIST Instrument Enables High-speed Chemical Imaging of Tissues
Researchers have demonstrated a dramatically improved technique for analyzing biological cells and tissues based on characteristic molecular vibration "signatures."
Innovative Technology Enables First Crystal Structure of mGlu5 Transmembrane Domain to be Determined
Several novel drug candidates have been identified to help treat specific neuropsychiatric disorders.
Capturing Cancer: A Powerful New Technique for Early Diagnosis
Researchers describe an innovative technique for early disease detection, which they call immunosignaturing.
Significant Step Towards Blood Test for Alzheimer's
Scientists have identified a set of 10 proteins in the blood which can predict the onset of Alzheimer’s, marking a significant step towards developing a blood test for the disease.
Potential Alzheimer’s Drug Prevents Abnormal Blood Clots in the Brain
Researchers have identified a compound that might halt the progression of Alzheimer’s by interfering with the role of plaque forming amyloid-ß.
CRI Finds Key to Identifying, Enriching Mesenchymal Stem Cells
Biomarker enables researchers to accurately characterize the properties and function of MSCs in the body.
Finding Could Revolutionize Drug Discovery
A study by researchers at IRB Barcelona reveals the existence of information highways that connect and correlate distant sites within a single protein.
Advanced Cell Culture Techniques for Cancer Drug Discovery
This review focuses on the culturing of cell lines representative of solid cancers in advanced cell culture conditions.
Detailed Brain Imaging Study to Help Unlock Root Causes of Dementia
Large population scanning heralds a new era in research to tackle dementia and a wide range of intractable diseases.

High-throughput Screening in Human Embryonic Stem Cells for Drug Discovery
Sabrina C. Desbordes, Senior Postdoctoral Fellow, PRBB-Center for Genomic Regulation (CRG), speaking at Screening Europe 2010

Development of an AlphaScreen Assay for Epigenetic Peptide-Protein Interactions: A Target-Family Approach to the Discovery of MBT Antagonists
Tim Wigle, Researcher, University of North Carolina, speaking at Probe Discovery 2009

T-Cell Monitoring of Clinical Samples – Precise and Robust Assays based on DNA Methylation Markers
Ulrich Hoffmueller, Chief Business Officer, Epiontis GmbH, speaking at European Biomarkers Summit 2009

Experiences in Fragment-Based Lead Discovery
Ben Davis, Principal Scientist, NMR, Vernalis, speaking at Screening Europe 2010

Excitement Over Automated Electrophysiology: Heat Activation of TRPV1 and Action Potentials of Stem Cell Derived Cardiomyocytes
Rodolfo Haedo, Nanion Technologies, General Manager, speaking at Ion Channel Targets 2010.

Quartz and Glass Nanopore Membranes for Ultra-low Noise Measurement of Ion Channel Activity
Prithwish Pal, Electronic Biosciences, Research Scientist, speaking at Ion Channel Targets 2010.

Developing Novel Chloride-Channel Inhibitors
Merritt Maduke, Stanford School of Medicine, Associate Professor, speaking at Ion Channel Targets 2010.

FBS by Biochemical Assays – Does This Make Sense?
Julian Woelcke, Associate Director, Novartis Pharma AG, speaking at Screening Europe 2010.

Development of an AlphsScreen HTS Assay for Low Affinity Epigenetic Peptide-Protein Interactions
Tim Wigle, Postdoc, University of North Carolina, speaking at Screening Europe 2010.

<< 8 9 10 11 12 13 14 >>
Showing Results 101 - 110 of 235
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv